Radja M. Badji

Qatar Science And Technology Park
Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Response to Letter to the Editor: Commending the Feasibility of CYP2C19 Pharmacogenetic Testing in Personalized Antiplatelet Therapy-Insights and Perspectives.

Response to Letter to the Editor: Commending the Feasibility of CYP2C19 Pharmacogenetic Testing in Personalized Antiplatelet Therapy-Insights and Perspectives.

Journal: Clinical therapeutics
Published: February 09, 2026

First National Expanded Genomic Newborn Screening Program in Qatar; A Pilot Study, Doha-Heidelberg Collaboration.

First National Expanded Genomic Newborn Screening Program in Qatar; A Pilot Study, Doha-Heidelberg Collaboration.

Journal: American journal of medical genetics. Part A
Published: December 13, 2025

From Biobank to Bedside: A Pilot Study on Returning Medically Actionable BRCA1/2 Results in Qatar's Precision Medicine Landscape.

From Biobank to Bedside: A Pilot Study on Returning Medically Actionable BRCA1/2 Results in Qatar's Precision Medicine Landscape.

Journal: Biomedicines
Published: November 09, 2025

Toward Personalized Anticoagulation: Clinical Predictors of Early Warfarin Response in Heart Valve Replacement Patients.

Toward Personalized Anticoagulation: Clinical Predictors of Early Warfarin Response in Heart Valve Replacement Patients.

Journal: Biomedicines
Published: November 03, 2025

Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative.

Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative.

Journal: Clinical therapeutics
Published: May 19, 2025

Dihydropyrimidine Dehydrogenase Deficiency (DPYD) Genotyping-Guided Fluoropyrimidine-Based Adjuvant Chemotherapy for Breast Cancer. A Cost-Effectiveness Analysis.

Dihydropyrimidine Dehydrogenase Deficiency (DPYD) Genotyping-Guided Fluoropyrimidine-Based Adjuvant Chemotherapy for Breast Cancer. A Cost-Effectiveness Analysis.

Journal: Clinical drug investigation
Published: November 21, 2024

QPGx-CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.

QPGx-CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.

Journal: Clinical and translational science
Published: February 26, 2024

Qatar genome: Insights on genomics from the Middle East.

Qatar genome: Insights on genomics from the Middle East.

Journal: Human mutation
Published: September 10, 2021

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar.

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar.

Journal: Frontiers in cellular and infection microbiology
Published: September 01, 2021

Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19.

Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19.

Journal: The Journal of clinical investigation
Published: January 19, 2021

Failure to replicate the association of rare loss-of-function variants in type I IFN immunity genes with severe COVID-19.

Failure to replicate the association of rare loss-of-function variants in type I IFN immunity genes with severe COVID-19.

Journal: medRxiv : the preprint server for health sciences
Published: January 05, 2021

Willingness to participate in genome testing: a survey of public attitudes from Qatar.

Willingness to participate in genome testing: a survey of public attitudes from Qatar.

Journal: Journal of human genetics
Published: January 23, 2020
Showing 1-12 of 14

Last Updated: 09/26/2026